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Abstract 
Objective: Expression of the de-adhesive extracellular matrix protein tenascin-C (TNC) is associated with the early 
postnatal development of articular cartilage which is both load-dependent and associated with chondrocyte differen-
tiation. We assessed morphological changes in the articular cartilage of TNC deficient mice at postnatal ages of 1, 4 
and 8 weeks compared to age-matched wildtype mice.
Results: Cartilage integrity was assessed based on hematoxylin and eosin stained-sections from the tibial bone using 
a modified Mankin score. Chondrocyte density and cartilage thickness were assessed morphometrically. TNC expres-
sion was localized based on immunostaining. At 8 weeks of age, the formed tangential/transitional zone of the articu-
lar cartilage was 27% thicker and the density of chondrocytes in the articular cartilage was 55% lower in wildtype than 
the TNC-deficient mice. TNC protein expression was associated with chondrocytes. No relevant changes were found 
in mice at 1 and 4 weeks of age. The findings indicate a role of tenascin-C in the post-natal maturation of the extracel-
lular matrix in articular cartilage. This might be a compensatory mechanism to strengthen resilience against mechani-
cal stress.
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Introduction
Tenascin-C (TNC) is a hexameric glycoprotein of the 
extracellular matrix (ECM) that shapes mechanical and 
biochemical cues within the cellular microenvironment 
of various tissues by the modulation of cell adhesion 
[1]. TNC has a modular composition containing a hep-
tad repeat region, epidermal growth factor (EGF)-like 
domains, fibronectin-type III repeats, and a fibrinogen-
like globe enabling alternatively spliced TNC isoforms 
to bind different ECM proteins, including syndecan, 
fibronectin and different integrins [1, 2] and subsequently 
modify the organization of the cytoskeleton and down-
stream signalling pathways via the dissolution of focal 
adhesions [3–5]. This de-adhesive action of TNC allows 
quiescent cells to enter an intermediate adhesive state 
that is compatible with tissue remodelling during mor-
phogenesis, wound healing and oncogenic transforma-
tion [1, 3, 6, 7].
Expression of TNC is regulated by growth factor- and 
cytokine-activated signaling pathways [1, 8–10] and is 
subject to direct and indirect, damage-related regulation 
by mechanical stress in connective tissue cells [1, 11–13]. 
Enhanced TNC expression is especially implicated in the 
adaptive response of musculoskeletal tissues (i.e. skeletal 
muscle, tendon and bone) to mechanical stress [11–15], 
which governs the post-natal differentiation, and regen-
erative response subsequent to the impact of a mechani-
cal challenge or insult, of this tissue family [14, 16–19].
Based on its particularly high abundance in the con-
densed mesenchyme, TNC has also been implicated 
in the differentiation of chondrocytes during cartilage 
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maturation in the embryo before TNC expression in 
these cartilage anlagen is lost and chondrocytes pro-
duce cartilage-specific extracellular matrix proteins 
[20–22]. Later, up to 4  weeks postpartum TNC expres-
sion reappears in the peripheral perichondrium [21, 23] 
and remains expressed in articular cartilage, but not in 
the growth plate, and decreases thereafter [16, 20, 24]. 
Recently, TNC has been found to be re-expressed subse-
quent to traumatic joint loading of the developed articu-
lar cartilage and to promote cartilage repair via a switch 
in extracellular matter synthesis [25].
Although proposed [26], and suggested by TNC’s con-
tribution to musculoskeletal remodelling [11–15] and 
load-dependent regenerative functional adaptations of 
joints after birth [27, 28]; it had never been tested experi-
mentally whether TNC participates in articular chon-
drocyte development and differentiation in long bone 
models, and remains functional throughout postnatal 
life. We thus hypothesized that TNC-deficient mice 
would demonstrate structural aberrations of articular 
cartilage in the first 2 months after birth when knee joints 
are first subjected to gravitational loading and chondro-
cyte volume and extracellular matrix production undergo 
marked alterations [24].
Main text
Methods
Study design
TNC-deficient mice (TNC −/−) and homozygous 
wildtype mice (TNC +/+) were generated by the breed-
ing of homozygous TNC-deficient mice, and homozy-
gous wildtype mice, respectively. Mice were ear marked, 
genotyped within the first 2 weeks after birth and subse-
quently housed in groups of 2–6 animals per cage. The 
parental homozygous TNC-deficient mice and homozy-
gous wildtype mice were derived from the breeding of 
heterozygous TNC-deficient mice (TNC +/+/). Skeletal 
tissue was collected from euthanized mice irrespective of 
sex, at 4 or 8 weeks of age and subjected to histological 
processing. The assessment of structural deficits (modi-
fied Mankin score, cell density in the articular cartilage, 
TNC expression in articular cartilage) was carried out in 
a blinded fashion.
Animals
TNC-deficient mice were derived from the original strain 
with a targeted insertion of a β-lactamase cassette in the 
NcoI site of exon 2 of the TNC gene [29] and back crossed 
with WT 129/SV mice. Mice were housed with 12:12-h 
light/dark cycle at a constant temperature of 22  °C in 
Macrolon type III cages (Indulab, Italy) under specific-
pathogen-free conditions with standard chow and water 
ad  libitum at the Department of Clinical Research, 
University of Berne, Switzerland. Animal health sta-
tus was daily inspected and the microbiological status 
inspected in sentinels. Genotype was determined by PCR 
on tail DNA [14]. Tail cutting was done after euthanasia.
Sample preparation and histology
The mice were anaesthetized with 5% isoflurane (Provet 
AG, Burgdorf, Switzerland) and euthanized by decapita-
tion. Skeletal elements of the explanted hindlimbs were 
fixed in 4% paraformaldehyde and shipped to the Uni-
versity of Kentucky. The tissue was processed by decal-
cification as described [30, 31], embedded in paraffin, 
sectioned at 5  μm thickness in parallel direction to the 
tibial axes, and subjected to standard hematoxylin and 
eosin (H&E) staining. Slides representing the distal femur 
from the diaphysis (proximal) to the articular surface of 
the knee (distal) and the proximal tibia from the articular 
surface to the diaphysis were shipped to the University of 
Zurich for morphological analysis.
Assessment of structural cartilage deficits
H&E stained sections of the coronary tibia were recorded 
at a four- and tenfold magnification on an IX50 micro-
scope via a DP72 digital camera (Olympus, Volketswil, 
Switzerland). A modified Mankin score was used to grade 
cartilage integrity from 0 to 7 points (i.e. normal struc-
ture to complete cartilaginous destruction) based on the 
staining of the cartilage structure and tidemark (Addi-
tional file 1: Figure S1, Additional file 2: Table S1; [32]). 
The employed scoring rubric has been shown to strongly 
correlate with the OARSI scoring [33] and has been used 
consistently in rodent [34, 35] and human specimens to 
grade mild to moderate cartilage defects [33]. Cell den-
sity within the articular cartilage was detected by point 
counting using a 25 by 25 µm grid that was placed on a 
randomly selected tenfold magnified microscopic field of 
each sample under application of the forbidden line rule. 
Thickness of the tangential/transitional zone of articular 
cartilage was determined from the average of three meas-
urements for the tangential distance in the center of the 
joint with the cellSens software (version 1.6, Olympus, 
Volketswil, Switzerland).
Immunohistochemical detection of tenascin‑C
Paraffin sections were processed essentially as described 
[36] but without preincubation with proteolytic enzymes. 
Deparaffinized sections were incubated with affin-
ity purified TNC specific antibody from rabbit (#473, 
1:100; [37]) or a negative control (rabbit antibody against 
serum response factor, [38]) and subsequently with horse 
radish peroxidase-coupled goat anti-rabbit antibody 
[#55676 (1:200; MP Biomedicals, Ohio, USA)]. Signal was 
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detected using AEC high sensitivity substrate (DAKO, 
Baar, Switzerland) and microscopically recorded.
Statistical analysis
We used SPSS by IBM (Armonk, NY, USA) for the sta-
tistical analysis and graphic representation of the data. A 
two-way ANOVA for the factors genotype and age fol-
lowed by Bonferroni post hoc analysis was performed, 
when equality of variance could be assumed based on a 
Levene’s test. A p-value < 0.05 was considered statistically 
significant.
Results
Animals
All animals entering the experiment were free of signs 
of stress and had a proper microbiological status. No 
adverse events were noted.
Cartilage structure
Figure  1a shows the results of the assessment using 
the modified Mankin score. No difference revealed 
in dependence on genotype (F = 0.701, p = 0.412, 
η2 = 0.034), age (F = 1.223, p = 0.315, η2 = 0.109), and the 
interaction between genotype × age (F = 0.291, p = 0.751, 
η2 = 0.028) (Fig 1).
Development of the tangential/transitional zone of 
articular cartilage was evident at 4 weeks of age in both 
wildtype and TNC-deficient mice. An effect of the geno-
type (F = 9.295, p = 0.010, η2 = 0.436) was determined for 
the thickness of the tangential/transitional zone of artic-
ular cartilage. However, thickness was not affected by 
age (F = 2.677, p = 0.128, η2 = 0.182) nor the interaction 
between genotype × age (F = 0.553, p = 0.471, η2 = 0.044). 
At 8  weeks of age the articular cartilage was thicker in 
wildtype than TNC-deficient mice (see Table 1).
Altered cell density in articular cartilage of tenascin‑C 
deficient mice
Figure  1b summarizes the measured cell density in the 
different groups. For cell density in articular cartilage, 
there was a significant effect of genotype (F = 6.899, 
p = 0.016, η2 = 0.256) and age (F = 11.952, p = 0.001, 
η2 = 0.544), and a trend for an interaction effect of 
age × genotype (F = 3.494, p = 0.083, η2 = 0.200). Post 
hoc analysis localized a significant difference (p = 0.011) 
between the TNC-deficient (359.4 ± 54.5 cells/mm2) and 
wildtype (160.8 ± 44.5 cells/mm2) mice at 8 weeks of age. 
Cell density between TNC-deficient and wildtype mice at 
one (p = 0.229) and 4 weeks (p = 0.544) of age did not dif-
fer significantly. In TNC-deficient mice cell density was 
lower at eight than 1  week of age (− 178.8 cells/mm2, 
p = 0.031). In wildtype mice, cell density was lower at 
eight than 1  week of age (− 281.0 cells/mm2, p = 0.001) 
and 4  weeks of age (− 279.7 cells/mm2, p = 0.001). The 
diameter of the epiphysis demonstrated an effect of age 
(F = 54.156, p < 8.5  10−9, η2 = 0.844), but no effect of 
Fig. 1 Effect of age and genotype on articular cartilage. Box whisker 
plots visualizing the median (central line), 25th and 75th percentiles 
(box), and highest and lowest values (whiskers) for the modified 
Mankin scores (a) and cell density (b) in the articular cartilage of 
wildtype and TNC-deficient mice at 1, 4 and 8 weeks of age. n = 4 
for all sample points, except for the 8 weeks of wildtype mice where 
n = 6. * and *** denote p < 0.05, and < 0.001, respectively, for the 
indicated difference
Table 1 Thickness of  the  tangential/transitional articular 
cartilage
Median ± standard deviation (n, number of independent replicas) of the average 
thickness of articular cartilage in wildtype (WT) and TNC-deficient (TNC-) mice at 
4 and 8 weeks of age. p-values of the differences are given
Thickness (μm) 4 weeks 8 weeks p-value
WT 125.7 ± 5.3 (4) 140.6 ± 19.8 (5) 0.124
TNC- 107.0 ± 10.9 (4) 108.0 ± 18.7 (4) 0.533
p-value 0.151 0.014
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genotype (F = 0.004, p = 0.951, η2 = 0.001), increasing 
similarly between one and 4 weeks of age in both geno-
types and then remained stable (Additional file 3: Figure 
S2).
Localization of tenascin‑C expression
Chondrocyte specific staining of TNC was identified in 
the tangential and transitional zone of the tibial cartilage 
in 4 and 8 weeks-old wildtype and TNC mice and in the 
bone marrow (Fig. 2; Additional file 4: Figure S3).
Discussion
Our study has examined the articular cartilage of TNC-
deficient mice at early age. The results indicate that TNC-
deficient mice demonstrate alterations in the maturation 
of the tibial articular cartilage at 8 weeks of age that do 
not seem to manifest in a gross pathology according to 
Mankin scores under native conditions. Our data imply 
that the reduction in chondrocyte cell density that char-
acterizes post-natal growth and maturation of skeletal 
development [24, 30, 39] is TNC-dependent.
Our immunohistochemical experiments localizing 
strong TNC expression to chondrocytes of the tan-
gential/transitional zones of 4- and 8-weeks-old mice 
confirm the association of TNC expression with the 
periphery of developing cartilage [16, 36]. This result 
indicates that chondrocyte-related TNC expression and 
differences in the density of this cell type in articular 
cartilage 8 weeks into development are associated. TNC 
expression is abundant in the territorial matrix of carti-
lage [16, 36] suggesting its involvement in the genesis of 
articular chondroytes and assembly of the chondrocyte 
matrix [21, 36]. Our observations imply that TNC is part 
of the mechanism regulating the increase in volume of 
articular cartilage, and extracellular matrix production 
from birth to 2 months of age in mice, when overall cell 
density is decreased [24]. Effects of TNC-deficiency on 
the thickness of cell layers had been documented during 
healing of compressed corneas [40] and trauma induced 
extracellular matrix synthesis in articular cartilage [25, 
36]. In this regard, the reduced thickness of articular car-
tilage in TNC-deficient mice at 8 weeks of age suggests a 
reduced capacity for extracellular matrix synthesis.
We observed that the tangential/transitional zone 
of articular cartilage was 30% thicker in wildtype than 
TNC-deficient mice at the age of 8 weeks when chondro-
cyte density in the wildtype mice was concurrently lower. 
The findings imply that the lower chondrocyte density 
in wildtype mice is in part explained by the enhanced 
deposition of extracellular matrix rather than a geno-
type effect on the proliferation or depletion of chondro-
cytes [41]. This contention is supported by the reciprocal 
relationship between the expression of TNC and carti-
lage-specific extracellular matrix proteins during chon-
drocyte differentiation [21], and between the cell density 
and thickness of articular cartilage [40]. Meanwhile, the 
decreased cell density in articular cartilage of wildtype 
mice between 4 and 8 weeks of age, when the thickness 
of articular cartilage was not significantly affected (12%, 
p = 0.124), suggests that cells were nevertheless lost dur-
ing this phase of postnatal development; contributing via 
a reduction in the capacity for extracellular matrix syn-
thesis [22], to the load-dependent thinning of articular 
cartilage during subsequent post-natal development [27].
We conclude that the morphological changes in the 
articular cartilage of TNC-deficient mice are subtle. 
They do not have a higher rate of growth abnormali-
ties or structural defects; however, structural differences 
Fig. 2 Tenascin-C expression in articular cartilage. TNC signal in a 4 
and 8 weeks old wildtype mouse and an 8 weeks old TNC-deficient 
mouse. The detected signal after detection with TNC antibody was 
compared to a negative control. Arrowheads point to TNC positive 
staining in association with chondrocytes. Bar 200 μm
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at 8  weeks of age are supportive of a TNC-dependent 
mechanism that leads to the deposition of the territorial 
matrix, rather than the down-regulation of chondrocyte 
density, in the 1 weeks after birth [19].
Limitations
Our histological assessment does with the exception of 
TNC expression only allow limited conclusions on the 
molecular pathways being implicated in the observed 
differences in post-natal development of articular carti-
lage. In this regard we also refer to the observation that 
the strain of TNC-deficient mice retains expression of 
an aberrant form of TNC that may lead to intracellular 
immunoreactivity [14, 42]; in line with the observed TNC 
staining in the cytoplasm of chondrocytes (Fig. 2). More-
over, we only observed a relatively small sample size of 
26 animals during the first 8 weeks of life. This is possibly 
too short a time period to observe the TNC-dependent 
repair mechanisms [43], as cartilage repair is comparably 
slow and sub-optimal [26, 44].
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Additional file 1: Figure S1. Articular cartilage of a TNC deficient mouse 
at 8 week of age. The articular cartilage is divided into 4 zones as depicted. 
The tidemark lies between the radial and the calcified zone.
Additional file 2: Table S1. List of the discriminative characteristics 
for the two considered structural aspects which respective points are 
summed to reveal the modified Mankin score.
Additional file 3: Figure S2. Box Whisker plots visualizing the median 
(central line), 25th and 75th percentiles (box), and highest and low-
est values (whiskers) for the diameter of the epiphysis in wildtype and 
TNC-deficient mice at 1, 4 and 8 week of age. n = 4 for all sample point, 
except for all sample points, except for the 8 week of wildtype mice where 
n = 6.***denotes p < 0.001 for the indicated difference.
Additional file 4: Figure S3. Tenascin-C expression in articular cartilage. 
TNC signal in articular cartilage of an 8-week-old wildtype and TNC-
deficient mouse. The detected signal was compared to a negative control. 
Arrowhead points to TNC positive staining in association with chondro-
cytes. Bar, 200 μm.
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